PharmD · Oregon

Collaborative Practice Agreement for Pharmacists in Oregon

No. Pharmacists practice independently here. Oregon calls it a CDTM Protocol.

Practice authorityIndependent practice
Written agreementNo agreement required
What Oregon calls itCDTM Protocol
Governing boardOregon Board of Pharmacy
Agreement familyCollaborative Practice
Research date2026-09-03 · clauses 2026-09-03

Oregon grants pharmacists direct statutory prescriptive authority for a Board-defined formulary (ORS 689.645: diabetic supplies, emergency insulin, albuterol, epinephrine, smoking-cessation aids, etc.) and for hormonal contraceptives (ORS 689.689) — grounded in statute and (for the formulary) a prior diagnosis by another prescriber, not a physician collaboration/CDTM agreement. A separate physician-agreement-based collaborative drug therapy management pathway was not confirmed in this research pass.

What the collaboration must look like

The rules the physician relationship has to follow. Each fact comes from the statute or board rule listed under sources.

Proximity

Not codified — left to the agreement

Supervision ratio

Not codified — no cap on file

Chart review

Not codified — left to the agreement

Meeting cadence

Not codified — left to the agreement

Prescriptive authority

Covered by the practice agreement · no controlled-substance authority

Neither statutory authority researched here extends to DEA-scheduled controlled substances; whether any separate Oregon pharmacist authority reaches controlled substances (e.g. naloxone, which is not scheduled) was not exhaustively checked.

Written agreement

Not required

Unconditional for the statutory formulary/contraceptive authority researched here — no physician agreement is required for either. Whether a distinct, agreement-based collaborative drug therapy management (CDTM) pathway also exists in Oregon (as in many other states) was not confirmed; treat as an open item rather than settled absence.

Practice ownership (corporate practice of medicine)

Non-licensee ownership permitted — Drug outlets register with the State Board of Pharmacy (ORS 689.305) and may be corporate entities — ORS 689.305 contemplates employees of a registered corporation, implying non-pharmacist/corporate ownership is permitted, consistent with the typical 'pharmacist-in-charge retains professional control' model seen in other states. The specific Oregon statute/rule naming a 'pharmacist-in-charge' safeguard was not located in this research pass — confirm before relying on it.

Materially more permissive than the physician/PA/NP/APRN entity-ownership rules above.

Legal sources for these rules (4)
The document: CDTM Protocol
What a Oregon CDTM Protocol must contain, who governs it and who signs: read the CDTM Protocol page on practiceagreement.com.

What a collaborating physician costs here

Typical monthly cost in Oregon

$500$600

Estimate for one Pharmacist. Standard-tier state.

About Oregon's rules

Oregon has no physician-supervision requirement for NP/CNS/CRNA and replaced PA 'supervision' with a non-supervisory 'collaboration agreement' (ORS 677.495-677.525, recodified by H.B. 4010, eff. June 6, 2024). CNM and PMHNP are population foci under the single NP license (OAR 851-050-0005), not separate license categories. CRNA/CNS entity co-ownership with physicians is unconfirmed — ORS 58.376 names only physicians, PAs, and NPs.

Other clinicians in Oregon: see the state overview.